Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes.

Clinical pharmacokinetics - 1 Apr 1997

Masson E, Zamboni W C

Abstract excerpt

Cancer chemotherapy doses are empirical in that the majority are administered at a fixed dose (mg/m2 or mg/kg). One reason for this is the intrinsic sensitivity of the tumour or host cells to one particular chemotherapy agent is unknown. Therefore, the likelihood of response or toxicity is unpred...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Circadian Rhythm
Share to Dose-Response Relationship, Drug

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Genotype

Share to Neoplasms

Share to Structure-Activity Relationship

Share to Treatment Outcome

Source

Identifiers

PMID: 9113440
DOI: 10.2165/00003088-199732040-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-9113440-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes.PMID 9113440Read ↗

Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.Semantic proximity Read ↗

How may anticancer chemotherapy with fluorouracil be individualised?Semantic proximity Read ↗

[Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].Semantic proximity Read ↗

Dose calculation of anticancer drugs.Semantic proximity Read ↗

Using genetic variation to optimize cancer chemotherapy.Semantic proximity Read ↗

Pharmacogenetics: a tool for individualizing antineoplastic therapy.Semantic proximity Read ↗

Pharmacogenomic progress in individualized dosing of key drugs for cancer patients.Semantic proximity Read ↗

Delivered dose: a drug-centric phenotype for chemotherapy dose individualization.Semantic proximity Read ↗

Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.Semantic proximity Read ↗

Can pharmacokinetic-pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?Semantic proximity Read ↗

Biochemical and clinical pharmacology of 5-fluorouracil.Semantic proximity Read ↗

Individualized drug and dose: the clinical pharmacologist's calling or curse?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.